2017 Weill Cornell Medicine Dean’s Entrepreneurship Lab and Entrepreneurship at Cornell Startup Symposium and Poster Session

Keynote Speakers included: 

Lewis C. Cantley, PhD, Co-Founder, Agios Pharmaceuticals (NASDAQ: AGIO); Co-Founder, Petra Pharma; Professor of Cancer Biology in Medicine, Weill Cornell Medicine; Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine/Ronald P. Stanton Clinical Cancer Program at New York-Presbyterian

Juan R. Cubillos-Ruiz, PhD, Assistant Professor of Microbiology & Immunology in Obstetrics and Gynecology; Instructor of Microbiology and Immunology in Medicine

Startup Presenters included: 

Acuamark Diagnostics, Inc.
Bernard M. Peperstraete, MD, President and Chief Executive Officer
AcuamarkDx’s novel detection technology simultaneously detects many types of cancer-specific markers at ultra-low levels in blood, to identify early cancer, often before symptoms occur, and when it is still highly curable.

Nomad Health
Justin Lambert, MBA, Vice President, Business Development
Nomad Health is the first online marketplace for temporary clinical work.

John Hui, MBA, Co-Founder & Executive Vice President
Twiage is an advanced cloud-based platform that uses best-in-class security technology to put telemedicine at the fingertips of emergency first responders and physicians to accelerate live-saving patient care.

OneThree Biotech
Neel S. Madhukar, PhD Candidate, Tri-Institutional Training Program in Computational Biology and Medicine, Weill Cornell Medicine Graduate School of Medical Sciences
OneThree Biotech uses artificial intelligence to identify the targets and side effects of drugs in development.

Kate Rochlin, PhD, Chief Scientific Officer
Immunovent is a platform company developing an innovative diagnostic, LAMB-Dx (Local Antibody Mucosal Brush Test), which relies on mucosal epithelial cell samples painlessly removed from the nose or mouth with a soft brush.

The 2017 Startup Symposium and poster session hosted world-class scientists, clinicians, investors and aspiring entrepreneurs on January 26, 2017 .